Created at	Source	Raw Value	Validated value
Jan. 23, 2022, 12:30 p.m.	usa	Adverse Events;Binding Antibodies in Serum against SARS-CoV-2 RBD Measured by CMIA;Neutralizing Antibodies in Serum against Live SARS-CoV-2 Measured by Neutralization Assay;Reactogenicity	Adverse Events;Binding Antibodies in Serum against SARS-CoV-2 RBD Measured by CMIA;Neutralizing Antibodies in Serum against Live SARS-CoV-2 Measured by Neutralization Assay;Reactogenicity